Literature DB >> 17475651

Temporal analysis of Andes virus and Sin Nombre virus infections of Syrian hamsters.

Victoria Wahl-Jensen1, Jennifer Chapman, Ludmila Asher, Robert Fisher, Michael Zimmerman, Tom Larsen, Jay W Hooper.   

Abstract

Andes virus (ANDV) and Sin Nombre virus (SNV) are rodent-borne hantaviruses that cause a highly lethal hemorrhagic fever in humans known as hantavirus pulmonary syndrome (HPS). There are no vaccines or specific drugs to prevent or treat HPS, and the pathogenesis is not understood. Syrian hamsters infected with ANDV, but not SNV, develop a highly lethal disease that closely resembles HPS in humans. Here, we performed a temporal pathogenesis study comparing ANDV and SNV infections in hamsters. SNV was nonpathogenic and viremia was not detected despite the fact that all animals were infected. ANDV was uniformly lethal with a mean time to death of 11 days. The first pathology detected was lymphocyte apoptosis starting on day 4. Animals were viremic and viral antigen was first observed in multiple organs by days 6 and 8, respectively. Levels of infectious virus in the blood increased 4 to 5 logs between days 6 and 8. Pulmonary edema was first detected ultrastructurally on day 6. Ultrastructural analysis of lung tissues revealed the presence of large inclusion bodies and substantial numbers of vacuoles within infected endothelial cells. Paraendothelial gaps were not observed, suggesting that fluid leakage was transcellular and directly attributable to infecting virus. Taken together, these data imply that HPS treatment strategies aimed at preventing virus replication and dissemination will have the greatest probability of success if administered before the viremic phase; however, because vascular leakage is associated with infected endothelial cells, a therapeutic strategy targeting viral replication might be effective even at later times (e.g., after disease onset).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17475651      PMCID: PMC1933362          DOI: 10.1128/JVI.00238-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  HFRS causing hantaviruses do not induce apoptosis in confluent Vero E6 and A-549 cells.

Authors:  Jonas Hardestam; Jonas Klingström; Karin Mattsson; Ake Lundkvist
Journal:  J Med Virol       Date:  2005-06       Impact factor: 2.327

2.  Effects of Ebola virus glycoproteins on endothelial cell activation and barrier function.

Authors:  Victoria M Wahl-Jensen; Tatiana A Afanasieva; Jochen Seebach; Ute Ströher; Heinz Feldmann; Hans-Joachim Schnittler
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

3.  Hantavirus pulmonary syndrome--five states, 2006.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2006-06-09       Impact factor: 17.586

4.  Sin Nombre viral RNA load in patients with hantavirus cardiopulmonary syndrome.

Authors:  Ruobing Xiao; Shu Yang; Fred Koster; Chunyan Ye; Chris Stidley; Brian Hjelle
Journal:  J Infect Dis       Date:  2006-10-10       Impact factor: 5.226

5.  Andes and Prospect Hill hantaviruses differ in early induction of interferon although both can downregulate interferon signaling.

Authors:  Christina F Spiropoulou; César G Albariño; Thomas G Ksiazek; Pierre E Rollin
Journal:  J Virol       Date:  2007-01-03       Impact factor: 5.103

6.  Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction.

Authors:  R S Hotchkiss; P E Swanson; B D Freeman; K W Tinsley; J P Cobb; G M Matuschak; T G Buchman; I E Karl
Journal:  Crit Care Med       Date:  1999-07       Impact factor: 7.598

7.  Human and rodent humoral immune responses to Andes virus structural proteins.

Authors:  Nicole D Tischler; Héctor Galeno; Mario Rosemblatt; Pablo D T Valenzuela
Journal:  Virology       Date:  2005-04-10       Impact factor: 3.616

8.  Characterization of shock in a hamster model of hantavirus infection.

Authors:  Matthew J Campen; Mary Louise Milazzo; Charles F Fulhorst; Chrys J Obot Akata; Frederick Koster
Journal:  Virology       Date:  2006-09-06       Impact factor: 3.616

9.  DNA vaccination with hantavirus M segment elicits neutralizing antibodies and protects against seoul virus infection.

Authors:  J W Hooper; K I Kamrud; F Elgh; D Custer; C S Schmaljohn
Journal:  Virology       Date:  1999-03-15       Impact factor: 3.616

10.  Person-to-person transmission of Andes virus.

Authors:  Valeria P Martinez; Carla Bellomo; Jorge San Juan; Diego Pinna; Raul Forlenza; Malco Elder; Paula J Padula
Journal:  Emerg Infect Dis       Date:  2005-12       Impact factor: 6.883

View more
  50 in total

Review 1.  The Syrian hamster model of hantavirus pulmonary syndrome.

Authors:  David Safronetz; Hideki Ebihara; Heinz Feldmann; Jay W Hooper
Journal:  Antiviral Res       Date:  2012-06-15       Impact factor: 5.970

2.  The Andes Orthohantavirus NSs Protein Antagonizes the Type I Interferon Response by Inhibiting MAVS Signaling.

Authors:  Jorge Vera-Otarola; Loretto Solis; Fernando Lowy; Valeria Olguín; Jenniffer Angulo; Karla Pino; Nicole D Tischler; Carola Otth; Paula Padula; Marcelo López-Lastra
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

3.  Role of vascular and lymphatic endothelial cells in hantavirus pulmonary syndrome suggests targeted therapeutic approaches.

Authors:  Erich R Mackow; Elena E Gorbunova; Nadine A Dalrymple; Irina N Gavrilovskaya
Journal:  Lymphat Res Biol       Date:  2013-09-11       Impact factor: 2.589

Review 4.  Treatment of hantavirus pulmonary syndrome.

Authors:  Colleen B Jonsson; Jay Hooper; Gregory Mertz
Journal:  Antiviral Res       Date:  2007-11-21       Impact factor: 5.970

5.  Choclo virus infection in the Syrian golden hamster.

Authors:  Eduardo J Eyzaguirre; Mary Louise Milazzo; Frederick T Koster; Charles F Fulhorst
Journal:  Am J Trop Med Hyg       Date:  2008-04       Impact factor: 2.345

6.  Pneumonitis in Syrian golden hamsters (Mesocricetus auratus) infected with Rio Mamoré virus (family Bunyaviridae, genus Hantavirus).

Authors:  Mary Louise Milazzo; Eduardo J Eyzaguirre; Charles F Fulhorst
Journal:  Virus Res       Date:  2014-07-23       Impact factor: 3.303

7.  Hamster-adapted Sin Nombre virus causes disseminated infection and efficiently replicates in pulmonary endothelial cells without signs of disease.

Authors:  David Safronetz; Joseph Prescott; Elaine Haddock; Dana P Scott; Heinz Feldmann; Hideki Ebihara
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

8.  Pathophysiology of hantavirus pulmonary syndrome in rhesus macaques.

Authors:  David Safronetz; Joseph Prescott; Friederike Feldmann; Elaine Haddock; Rebecca Rosenke; Atsushi Okumura; Douglas Brining; Eric Dahlstrom; Stephen F Porcella; Hideki Ebihara; Dana P Scott; Brian Hjelle; Heinz Feldmann
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

9.  Regulatory T cell-like responses in deer mice persistently infected with Sin Nombre virus.

Authors:  Tony Schountz; Joseph Prescott; Ann C Cogswell; Lauren Oko; Katy Mirowsky-Garcia; Alejandra P Galvez; Brian Hjelle
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-17       Impact factor: 11.205

10.  The detection of vascular endothelial growth factor in serum of patients with hemorrhagic fever with renal syndrome.

Authors:  Man Li; Yuqiang Ji; Yanying Dong; Yan Zhou; Huixun Ren; Ming Xie
Journal:  Inflammation       Date:  2013-08       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.